Outcome of Patients with ALK plus NSCLC and Brain Metastases in Relation to Disease Burden and Clinical Management

被引：0
|
作者：
De Petris, Luigi [1 ]
Friesland, Signe [1 ]
Brodin, Daniel [2 ]
Carstens, Hanna [1 ]
Falkenius, Johan [1 ]
Grundberg, Oscar [2 ]
Lofdahl, Magnus [2 ]
Helleday, Clara Lenneby [1 ]
Karimi, Reza [2 ]
Ojdahl-Boden, Anna [2 ]
Tsakonas, Georgios [1 ]
Ekman, Simon [1 ]
Kolbeck, Karl-Gustav [2 ]
机构：
[1] Karolinska Univ Hosp, Oncol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Resp Med & Allergol, Stockholm, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
ALK; WBRT; CNS Metastasis; 2nd generation ALKi;
D O I：
10.1016/j.jtho.2016.11.1294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03b-013
引用
收藏
页码：S940 / S941
页数：2
相关论文
共 50 条
  • [21] Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management.
    Otterson, Gregory Alan
    Riely, Gregory J.
    Shaw, Alice Tsang
    Crino, Lucio
    Kim, Dong-Wan
    Martins, Renato
    Salgia, Ravi
    Zhou, Caicun
    Solomon, Benjamin J.
    Wilner, Keith D.
    Polli, Anna
    Tang, Yiyun
    Bartlett, Cynthia Huang
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Lorlatinib in patients with ALK plus NSCLC treated beyond initial disease progression
    Ou, S. I.
    Solomon, B.
    Shaw, A.
    Gadgeel, S. M.
    Besse, B.
    Soo, R. A.
    Abbattista, A.
    Thurm, H.
    Toffalorio, F.
    Wiltshire, R. J.
    Bearz, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S842 - S842
  • [23] Economic burden of brain metastases in patients with anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung
    Lin, Huamao Mark
    Pan, Lucy
    Hou, Peijie
    Huang, Hui
    Desai, Avinash
    Jahanzeb, Mohammad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [24] Crizotinib Outcome and Post-Progression Management in ALK plus NSCLC: IFCT-1302 CLINALK
    Duruisseaux, Michael
    Besse, Benjamin
    Cadranel, Jacques
    Perol, Maurice
    Quoix, Elisabeth
    Mazieres, Julien
    Descourt, Renaud
    Dansin, Eric
    Audigier-Valette, Clarisse
    Moreau, Lionel
    Hureaux, Jose
    Veillon, Remi
    Otto, Josiane
    Madroszyk, Anne
    Cortot, Alexis B.
    Guichard, Francois
    Boudou-Rouquette, Pascaline
    Langlais, Alexandra
    Missy, Pascale
    Morin, Franck
    Zalcman, Gerard
    Moro-Sibilot, Denis
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S237 - S237
  • [25] Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients
    Gil, Michal
    Knetki-Wroblewska, Magdalena
    Nizinski, Przemyslaw
    Strzemski, Maciej
    Krawczyk, Pawel
    ANNALS OF MEDICINE, 2023, 55 (01) : 1018 - 1028
  • [26] Detection of brain metastases in patients having had surgery for NSCLC - an outcome audit
    Moholkar, S.
    Entwisle, J. J.
    Joynson, C.
    LUNG CANCER, 2009, 63 : S19 - S19
  • [27] Upfront and repeated stereotactic radiosurgery in patients with brain metastases from NSCLC - Clinical outcome and validation of prognostic scores
    Kraemer, Anna
    Adeberg, Sebastian
    Kronsteiner, Dorothea
    Koenig, Laila
    Schunn, Fabian
    Bozorgmehr, Farastuk
    Christopoulos, Petros
    Eichkorn, Tanja
    Rieken, Stefan
    Debus, Jurgen Peter
    El Shafie, Rami
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 156 - 156
  • [28] Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
    Tian, Yaru
    Zhai, Xiaoyang
    Tian, Hairong
    Jing, Wang
    Zhu, Hui
    Yu, Jinming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10083 - 10092
  • [29] EPIDEMIOLOGICAL, CLINICAL AND HUMANISTIC BURDEN AMONG ALK plus NON-SMALL CELL LUNG CANCER (ALK plus NSCLC) PATIENTS TREATED WITH FIRST-LINE ALK INHIBITORS: RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR)
    Pan, X.
    Kwon, C. S.
    Garib, S. A.
    Forsythe, A.
    Lin, H. M.
    VALUE IN HEALTH, 2019, 22 : S56 - S56
  • [30] Outcomes in patients with NSCLC with brain metastases
    Valiyaveettil, D.
    Malik, M.
    Joseph, D.
    Ahmed, S. F.
    Sindhusha, K.
    ANNALS OF ONCOLOGY, 2017, 28
12345